December 09, 2016 2:46 AM ET

Biotechnology

Company Overview of NanoValent Pharmaceuticals, Inc.

Company Overview

NanoValent Pharmaceuticals, Inc. develops drug delivery vaccines and cancer applications for Polymerized Liposomal Nanoparticles (PLNs). The company was founded in 2006 and is based in Bozeman, Montana.

910 Technology Boulevard

Suite G

Bozeman, MT 59718

United States

Founded in 2006

Phone:

406-586-8420

Fax:

406-586-8421

Key Executives for NanoValent Pharmaceuticals, Inc.

President
Co-Founder and Chief Technology Officer
Chief Medical Officer
Age: 71
Chief Operating Officer
Compensation as of Fiscal Year 2016.

NanoValent Pharmaceuticals, Inc. Key Developments

NanoValent Pharmaceuticals Promotes Mark Lewis to Chief Operating Officer

NanoValent Pharmaceuticals has promoted Mark Lewis to chief operating officer. The new COO has more than 30 years of international commercial and operations expertise received primarily in the area of oncology. He has worked at various pharmaceutical companies including Amersham International (now GE), Chiron (now Novartis) and Farmitalia (now Pfizer). He has spent 10 years as a management consultant, working at Hill & Knowlton and Quintiles. Most recently, Lewis served as managing director for Europe at SuperGen (now Otsuka Pharmaceutical) between 2006 and 2010, and was senior vice president of Ascalon Inc. from 2010 until 2012.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NanoValent Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.